| US-DMF LIST |
|
|
| Product Name |
US-DMF No. |
WC |
| Bivalirudin |
DMF 25531 |
Available |
| Eptifibatide |
DMF 27651 |
Available |
| Liraglutide |
DMF 29302 |
|
| Icatibant Acetate |
DMF 28496 |
|
| Octreotide Acetate |
DMF 30249 |
|
| Teriparatide Acetate |
DMF 32144 |
|
| Ganirelix Acetate |
DMF 033546 |
|
| Ziconotide Acetate |
DMF 33139 |
|
| Linaclotide |
DMF 035812 |
|
|
|
|
|
|
|
| Chinese cGMP APIs |
|
|
| Product Name |
GMP Certificate No. |
Local GMP |
| Levosimendan |
SC20120022 |
|
| Thymosin alpha1 |
SC20140047 |
|
| Enfuvirtide |
SC20140098 |
|
| Octreotide Acetate |
SC20150121 |
|
| Somatostatin |
SC20150121 |
|
| Thymopentin |
SC20150121 |
|
| Carbetocin |
SC20160013 |
|
| Atosiban |
SC20170065 |
|
|
|
|
| Research Peptide APIs for Regulatory Market |
|
|
| Product Name |
US-DMF File Point |
Stage |
| Semaglutide |
In the middle of 2023 |
PV finished |
| Degarelix |
By the end of 2023 |
PV finished |
| Exenatide |
By the end of 2023 |
PV finished |
| Teduglutide |
Bye the end of 2024 |
small trial |
| Cetrorelix |
By the end of 2023 |
PV finished |
| Tirzepatide |
In the middle of 2024 |
small trial finished |
Shengnuo bio PRODUCT
| Contacts |
Roleagh |
| Tel |
86-28-88203630 |
| Fax |
86-28-88203630 |
| Email |
roleagh@gmail.com |
| QQ |
2539328606 |
| Facebook |
LEI LI |
About Shengnuo
Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.